Appendix 4. Description of interventions (part3).

Character- istic	Quan SL, 2008	Tian X, 2007	Wang DG, 2003	Wang WH, 2006	Wang XL, 2004	Xu CB, 2000	Xu SG, 2002	Zhang G, 2005
Intervention (s) [route, fre- quency, total dose/day]	I: Xuezhikang orally, 2 times a day, 1.2 g/day	I: Xiaozhiling orally, 2 times a day, 600 ml/day	I: Xuezhikang orally, 2 times a day, 1.2 g/day	I: Xuezhikang orally, 2 times a day, 1.2 g/day	I: Xuezhikang orally, 2 times a day, 1.2 g/day	I: Xuezhikang orally, daily, 2 capsules/ day	I: Xuezhikang orally, 2 times a day, 1.2 g/day	I: Xuezhikang orally, 2 times a day, 1.2 g/day
Control(s) [route, fre- quency, total dose/day]	C: simvastatin orally, daily, 20 mg/day	C: simvastatin orally, daily, 10 mg/day	C: pravastatin orally, daily, 10 mg/day	C: atorvas- tatin orally, daily, 10 mg/day	C: simvastatin orally, daily, 20 mg/day	C: pravastatin orally, daily, 1/2 tablet/ day	C: lovastatin orally, daily, 20 mg/day	C: atorvas- tatin orally, daily, 10 mg/day

Footnotes

C: control; I:

intervention